NYSEARCA:FFTY Innovator IBD 50 ETF (FFTY) Price, Holdings, & News $29.60 -2.36 (-7.38%) Closing price 02/21/2025 04:10 PM EasternExtended Trading$29.88 +0.27 (+0.93%) As of 02/21/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatings About Innovator IBD 50 ETF (NYSEARCA:FFTY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Innovator IBD 50 ETF alerts:Sign Up Key Stats Today's Range$29.58▼$31.8250-Day Range$28.39▼$33.7552-Week Range$22.95▼$34.26Volume391,703 shsAverage Volume181,174 shsMarket Capitalization$96.20 millionAssets Under Management$83.02 millionDividend Yield2.03%Net Expense Ratio0.80%Aggregate RatingModerate Buy ETF OverviewThe Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.Read More… Innovator IBD 50 ETF ExpensesTypeFFTYStrategy ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.70%0.47%0.56%0.51%0.53%Other Expenses0.39%0.39%0.50%0.57%0.53%Total Expense1.09%0.62%0.72%0.73%0.71%Fee Waiver-0.29%-0.42%-0.50%-0.66%-0.56%Net Expense0.80%0.53%0.62%0.58%0.60% Receive FFTY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Innovator IBD 50 ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address FFTY ETF News HeadlinesDow Jones Futures Rise, Market Eyes Highs; New Tesla Model Y Deliveries Sped UpFebruary 18, 2025 | msn.comDow Jones Futures: Market Rally Just Below Highs, With Amazon, Broadcom Near Buy Points; What To Do NowFebruary 14, 2025 | msn.com$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers. The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail.February 22, 2025 | Altimetry (Ad)Three Stocks Hover Near Buy Points In Outstanding Week For IBD 50February 14, 2025 | msn.comDow Jones Futures: Trump Tariff News Drives Market To Cusp Of Highs; What To Do NowFebruary 13, 2025 | msn.comMotilal Oswal Nasdaq Q 50 ETF (MONQ50.NS)November 3, 2024 | finance.yahoo.comSee More Headlines FFTY ETF - Frequently Asked Questions How have FFTY shares performed this year? Innovator IBD 50 ETF's stock was trading at $28.59 at the start of the year. Since then, FFTY shares have increased by 3.5% and is now trading at $29.60. View the best growth stocks for 2025 here. Who are Innovator IBD 50 ETF's major shareholders? Innovator IBD 50 ETF's top institutional shareholders include IronBridge Private Wealth LLC (8.86%), Chicago Partners Investment Group LLC (1.64%), IHT Wealth Management LLC (1.36%) and Two Sigma Investments LP (1.22%). How do I buy shares of Innovator IBD 50 ETF? Shares of FFTY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Innovator IBD 50 ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Innovator IBD 50 ETF investors own include Bristol-Myers Squibb (BMY), Chevron (CVX), Charles Schwab (SCHW), Comcast (CMCSA), Edwards Lifesciences (EW), McKesson (MCK) and Toronto-Dominion Bank (TD). Fund Details IssuerInnovator Capital Management Fund NameInnovator IBD 50 ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:FFTY Inception Date4/9/2015 Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkIBD 50 Index CategoryBroad Equity FocusStrategy Development LevelBlended Development RegionGlobal Number of Holdings51 Fund Statistics Assets Under Management$83.02 million Average Daily Volume$199,730.80 Discount/Premium0.03% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorInnovator Capital Management, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume144 Put Options80 Call Options64 Short Interest70,600 shs Miscellaneous Outstanding Shares3,250,000Beta1.50 Creation Unit50,000 Creation Fee$250.00 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report Top 10 FFTY HoldingsDoximity (NASDAQ:DOCS)Holding Weight: 4.87%Palantir Technologies (NASDAQ:PLTR)Holding Weight: 3.92%Root (NASDAQ:ROOT)Holding Weight: 3.68%Rocket Lab USA (NASDAQ:RKLB)Holding Weight: 3.64%Hims & Hers Health (NYSE:HIMS)Holding Weight: 3.61%Stride (NYSE:LRN)Holding Weight: 3.46%Axon Enterprise (NASDAQ:AXON)Holding Weight: 3.39%Sprouts Farmers Market (NASDAQ:SFM)Holding Weight: 3.39%Grail (NASDAQ:GRAL)Holding Weight: 3.30%Celestica Inc.Holding Weight: 3.09%Full Holdings DetailsFFTY Sector ExposureFFTY Industry Exposure This page (NYSEARCA:FFTY) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovator IBD 50 ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovator IBD 50 ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
